Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Pacer--PLAINTIFFS’ REPLY BRIEF IN SUPPORT OF MOTION TO CONTINUE DISCOVERY AND TRIAL DATE

Last time I posted this I was ridiculed and called a basher and worse.

So while this does not end the litigation it does mean that ARM

does not infringe on the 584 and PTSC is so stipulating

While I cannot tell whether the 584 was actually worth anything relative to to the other patents the loss will serve to strengthen the J's resolve

to continue to see this through and preclude IMO others from settling

from teh pacer....

accordingly, there is no longer any case or controversy between Plaintiffs and ARM. 2 Contrary to Toshiba's assertions, Plaintiffs have not asked for an "indefinite" or "open-ended" continuance. Rather, Plaintiffs seek only a two month continuance in order to complete discovery in a fair manner is, at best, greatly exaggerated. Indeed, Toshiba has presented no evidence of actual or likely prejudice in relation to either its customers or in its sales because of this lawsuit. Accordingly, Plaintiffs’ motion should be granted.

Share
New Message
Please login to post a reply